CurrentReport Blog In a recent development, the office of the Syrian President announced that First Lady Asma al-Assad has been diagnosed with acute myeloid leukemia. This announcement was made public in a press statement on Tuesday, capturing the attention of both national and international news outlets.
Asma al-Assad, who previously triumphed over breast cancer in 2019, now faces a new health challenge. The statement from the president’s office detailed that she will undergo a specialized treatment protocol. This treatment will necessitate her isolation, leading to a temporary withdrawal from her public duties and engagements.
The official statement read, “First Lady, Asma al-Assad has been diagnosed with acute myeloid leukemia.” This news has elicited a wave of concern and support from across the globe as the First Lady embarks on this new health journey.
Given the nature of her treatment, Asma al-Assad will step away from her public roles and responsibilities. This period of isolation is critical for her health and recovery as she undergoes intensive medical care.
Her previous battle with breast cancer was marked by resilience and strength, earning her widespread admiration. Supporters are hopeful that she will exhibit the same determination and fortitude in overcoming leukemia.
